Clinical trial
Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among…
NCT00483054 · Bamrasnaradura Infectious Diseases Institute, Other · Completed
Key facts
| NCT number | NCT00483054 |
|---|---|
| Title | Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin |
| Official title | Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin |
| Acronym | N2R |
| Lead sponsor | Bamrasnaradura Infectious Diseases Institute, Other |
| Collaborators | Mahidol University Chulalongkorn University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Tuberculosis |
| Intervention type | Drug |
| Interventions | efavirenz, nevirapine |
| Enrollment | 142 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2010 |
| First posted | Jun 6, 2007 |
| Last update posted | Nov 22, 2011 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: